CANTOS: Dousing the Fire Within to Reduce CVD
Dr O ’ Donoghue discusses preliminary results from the CANTOS trial of canakinumab, a unique anti-inflammatory agent which represents a new pathway for treating cardiovascular disease.
Source: Medscape Cardiology Podcast - Category: Cardiology Authors: Medscape Source Type: podcasts